Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02145923
What this trial is testing

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Who this might be right for
Neutropenic EnterocolitisMyeloablative Chemotherapy Induced Bone Marrow Aplasia
Burnasyan Federal Medical Biophysical Center 16
Large-scale testing (Phase 3)Study completedNCT03106662
What this trial is testing

Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematopoietic Stem Cell Transplantation
Ankara University 6
Testing effectiveness (Phase 2)Study completedNCT01711788
What this trial is testing

Intrabone Infusion of Umbilical Cord Blood Stem Cells

Who this might be right for
Hematopoietic Stem Cell Transplantation
Henrique Bittencourt, MD, PhD 15
Testing effectiveness (Phase 2)Study completedNCT00117442
What this trial is testing

Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood

Who this might be right for
Breast CancerLung CancerOvarian Cancer
Amgen 61
Not applicableEnded earlyNCT00038818
What this trial is testing

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaMultiple MyelomaNon Hodgkin's Lymphoma+2 more
M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)Looking for participantsNCT02781922
What this trial is testing

Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)

Who this might be right for
Hypoplastic Left Heart SyndromeSingle Ventricle
Metcela Inc. 40
Early research (Phase 1)Looking for participantsNCT07438067
What this trial is testing

EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

Who this might be right for
EBV-DNA Viremia
Daihong Liu 18
Testing effectiveness (Phase 2)Looking for participantsNCT07105579
What this trial is testing

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaRelapse
First Affiliated Hospital of Zhejiang University 31
Testing effectiveness (Phase 2)Study completedNCT01781390
What this trial is testing

Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Mesoblast, Inc. 106
Early research (Phase 1)Ended earlyNCT01630564
What this trial is testing

Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02497443
What this trial is testing

Safety of Autologous MSC Infusion to Treat Epilepsy

Who this might be right for
Epilepsy
Ministry of Public Health, Republic of Belarus 60
Testing effectiveness (Phase 2)Study completedNCT00795548
What this trial is testing

Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Heinrich-Heine University, Duesseldorf 30
Testing effectiveness (Phase 2)UnknownNCT01758367
What this trial is testing

Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation

Who this might be right for
Recurrent Adult Acute Myeloid Leukemia
Chinese PLA General Hospital 30
Early research (Phase 1)UnknownNCT02619734
What this trial is testing

Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease

Who this might be right for
Chronic Leg UlcerSickle Cell Disease
Federal University of Bahia 40
Testing effectiveness (Phase 2)Ended earlyNCT00416884
What this trial is testing

Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT01142232
What this trial is testing

Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Attaya Suvannasankha 60
Not applicableStudy completedNCT00316381
What this trial is testing

Stem Cell Therapy to Improve Myocardial Function in Patients With Acute Myocardial Infarction

Who this might be right for
Myocardial Infarction
Silesian School of Medicine 200
Post-approval studies (Phase 4)Study completedNCT04243681
What this trial is testing

Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis

Who this might be right for
Cirrhosis, Liver
Asian Institute of Gastroenterology, India 5
Early research (Phase 1)UnknownNCT04347967
What this trial is testing

Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
Acute Respiratory Distress Syndrome
Meridigen Biotech Co., Ltd. 18
Next Page